AIM movers: ImmuPharma autoimmune therapy success and ex-dividends

ImmuPharma (LON: IMM) says the preclinical research programme for autoimmune therapy P140 should pave the way for earlier, more accurate diagnostics, as well as better identification and improved monitoring of patients. Detailed data is not being published. The share price jumped 83.3% to 2.2p.

Data analytics technology provider Cirata (LON: CRTA) says that the fourth quarter bookings were the best since the second quarter of 2022. They were $3m of bookings in the fourth quarter which is always the strongest period, taking the total for the year to $7.1m, which is slightly lower than the year before. Fourth quarter cash overheads were reduced to $5m, while the quarterly cash burn was $3.2m. There was cash of $9.7m at the end of 2024. The annualised cash overhead is $20m and it should fall further to $17m. The share price recovered 19.4% to 25.5p.

- Advertisement -

Scancell (LON: SCLP) says that its Modi-1 Moditope vaccine in combination with checkpoint inhibitors shows an improved response rate in head and neck cancer in a phase 2a study. This means the study will continue to full recruitment to up to 21 patients. The addressable market for Modi-1 could be $3bn. There will be additional data later this year. The share price improved 5.33% to 10.375p.

Tercio Capital has increased its stake in Tortilla Mexican Grill (LON: MEX) from 3.25% to 4.25%. It went above 3% in December. The share price is 5.1% ahead at 51.5p.

Pawnbroker H & T (LON: HAT) says 2024 trading was in line with expectations. It is on course to improve pre-tax profit from £26.4m to £29m. The pledge book increased 26% to £127m. There were more loans over £5,000. There was strong demand for lower price jewellery, which boosted retail sales. National Insurance changes will increase costs by £2m/year. The year end is being changed to September this year. The share price rose 2.83% to 345.5p.

FALLERS

- Advertisement -

Impax Asset Management (LON: IPX) reports assets under management falling 8% to £34.1bn in the quarter to December 2024. The ending of the smaller mandate with St James’s Place was a factor and the larger mandate will hit the current quarter. There was also a negative market performance. The rate of outflows elsewhere is slowing. The share price dipped 4.64% to 231.25p.

Jeffries has changed its recommendation on video games company Team 17 (LON: TM17) from hold to buy and raised its share price target from 230p to 360p. The share price fell 2.17% to 225p.

Ex-dividends

Cohort (LON: CHRT) is paying an interim dividend of 5.25p/share and the share price increased 12.5p to 1142.5p.

Dotdigital (LON: DOTD) is paying a final dividend of 1.1p/share and the share price rose 0.25p to 84.25p.

Iomart (LON: IOM) is paying an interim dividend of 1.3p/share and the share price fell 1.4p to 78p.

Latest News

Subscribe to the UK Investor Magazine email newsletter

Register for our free email newsletter and receive the latest investment news, podcasts, event information and offers.

More Articles Like This